HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Antagonism of leukocyte adherence by synthetic fibronectin peptide V in a rat model of transient focal cerebral ischemia.

AbstractOBJECTIVE:
Activated polymorphonuclear leukocytes (PMNs) seem to be directly involved in potentiating ischemic brain injury. Recent work in our laboratory demonstrated that synthetic fibronectin peptides significantly inhibit PMN accumulation in ischemic tissue, reduce the size of infarction, and reduce neurological dysfunction after transient focal cerebral ischemia in rats. The purpose of this study was to examine any dose-related effects (Experiment 1) and the optimal timing of the administration (Experiment 2) of synthetic fibronectin peptide V (FN-C/H-V) to further substantiate the role of the peptide in ameliorating cerebral ischemic damage.
METHODS:
Fifty-six animals were included in the study. We evaluated the efficacy of FN-C/H-V on PMN accumulation in ischemic tissue, infarct size, and neurological outcomes in rats subjected to 1 hour of cerebral ischemia and 48 hours of reperfusion.
RESULTS:
In Experiment 1, the animals receiving FN-C/H-V at a dose of 10 to 15 mg/kg of body weight per injection showed significant reduction of PMN accumulation, reduction of infarct size, and improvement of neurological outcomes at 48 hours after reperfusion compared to untreated animals (P < 0.05). In Experiment 2, the animals receiving FN-C/H-V within 3 hours after reperfusion also showed significantly better results than untreated animals (P < 0.05). Despite the treatment delay, the administration of FN-C/H-V inhibited PMN accumulation after reperfusion but did not reduce the size of infarction when administered 6 hours after reperfusion.
CONCLUSION:
These data suggest that relatively late postischemic administration of FN-C/H-V is effective in brain protection after ischemia/reperfusion.
AuthorsK Yanaka, P J Camarata, S R Spellman, J B McCarthy, L T Furcht, W C Low
JournalNeurosurgery (Neurosurgery) Vol. 40 Issue 3 Pg. 557-63; discussion 563-4 (Mar 1997) ISSN: 0148-396X [Print] UNITED STATES
PMID9055296 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Fibronectins
  • Peptide Fragments
  • Peroxidase
Topics
  • Animals
  • Brain Damage, Chronic (immunology)
  • Cerebral Infarction (immunology)
  • Dose-Response Relationship, Drug
  • Fibronectins (pharmacology)
  • Ischemic Attack, Transient (immunology)
  • Leukocyte Adherence Inhibition Test
  • Leukocyte Count (drug effects)
  • Leukocytes (drug effects, immunology)
  • Male
  • Neurologic Examination (drug effects)
  • Peptide Fragments (pharmacology)
  • Peroxidase (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: